{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:44:11Z","timestamp":1762505051167},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1995,6,1]],"date-time":"1995-06-01T00:00:00Z","timestamp":801964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1995,6]]},"DOI":"10.1007\/bf02065528","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T18:49:01Z","timestamp":1123872541000},"page":"1226-1230","source":"Crossref","is-referenced-by-count":22,"title":["Exacerbation of primary biliary cirrhosis during interferon-\u03b12b therapy for chronic active hepatitis C"],"prefix":"10.1007","volume":"40","author":[{"given":"T.","family":"Maeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Iwamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Saibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02065528_CR1","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM198911303212204","volume":"321","author":"AM Di-Bisceglie","year":"1989","unstructured":"Di-Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH: Recombinant alpha interferon therapy for chronic hepatitis C. A randomized, double blind, placebo-controlled trial. N Engl J Med 321:1506\u20131510, 1989","journal-title":"N Engl J Med"},{"key":"BF02065528_CR2","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198911303212203","volume":"321","author":"GL Davis","year":"1989","unstructured":"Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Givas A, Hepatitis Interventional Therapy Group: Treatment of chronic hepatitis with recombinant interferon alpha: A multicenter randomized, controlled trial. N Engl J Med 321:1501\u20131506, 1989","journal-title":"N Engl J Med"},{"key":"BF02065528_CR3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/hep.1840130302","volume":"13","author":"P Marcellin","year":"1991","unstructured":"Marcellin P, Boyer N, Giostra E, Degott C, Courouce AM, Degos F, Coppere H, Cales P, Couzigou P, Benhamou J-P: Recombinant human alpha interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized, controlled trial from France. Hepatology 13:393\u2013397, 1991","journal-title":"Hepatology"},{"key":"BF02065528_CR4","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0140-6736(89)90157-8","volume":"1","author":"M Schultz","year":"1989","unstructured":"Schultz M, Muller R, Von zur Muhlen A, Brabant G: Induction of hyperthyroidism by interferon-alpha-2b. Lancet 1:1452, 1989 (letter)","journal-title":"Lancet"},{"key":"BF02065528_CR5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/gut.33.6.855","volume":"33","author":"P Mercell","year":"1992","unstructured":"Mercell P, Pouteau M, Renard P, Grynblat J-M, Colas Linhart N, Bardet P, Bok B, Benhamou J-P: Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C. Gut 33:855\u2013856, 1992","journal-title":"Gut"},{"key":"BF02065528_CR6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7326\/0003-4819-115-3-178","volume":"115","author":"LE Ronnblom","year":"1991","unstructured":"Ronnblom LE, Alm GV, Oberg KE: Autoimmunity after alpha-interferon therapy for malignant carcinoid tumor. Ann Intern Med 115:178\u2013183, 1991","journal-title":"Ann Intern Med"},{"key":"BF02065528_CR7","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/0016-5085(91)90547-X","volume":"101","author":"MO Silva","year":"1991","unstructured":"Silva MO, Reddy KR, Jeffers LJ, Hill M, Schiff ER: Interferon-induced chronic hepatitis. Gastroenterology 101:840\u2013842, 1991","journal-title":"Gastroenterology"},{"key":"BF02065528_CR8","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/0016-5085(92)90786-X","volume":"102","author":"M Shindo","year":"1992","unstructured":"Shindo M, Di Bisceglie AM, Hoofnagle JH: Acute exacerbation of liver disease during interferon alpha therapy for chronic hepatitis C. Gastroenterology 102:1406\u20131408, 1992","journal-title":"Gastroenterology"},{"key":"BF02065528_CR9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2796.1990.tb00144.x","volume":"227","author":"LE Ronnblom","year":"1990","unstructured":"Ronnblom LE, Oberg KE, Alm GV: Possible induction of systemic lupus erythematosus by interferon treatment in a patient with a malignant carcinoid tumor. Int J Med 227:207\u2013210, 1990","journal-title":"Int J Med"},{"key":"BF02065528_CR10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1600-0609.1986.tb02290.x","volume":"36","author":"EA Abdi","year":"1986","unstructured":"Abdi EA, Brien W, Venner PM: Auto-immune thrombocytopenia related to interferon therapy. Scand J Haematol 36:515\u2013519, 1986","journal-title":"Scand J Haematol"},{"key":"BF02065528_CR11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1097-0142(19880301)61:5<869::AID-CNCR2820610503>3.0.CO;2-I","volume":"61","author":"GA Pangalis","year":"1988","unstructured":"Pangalis GA, Griva E: Recombinant alpha-2b-interferon therapy in untreated, stages A and B chronic lymphocytic leukemia. Cancer 61:869\u2013872, 1988","journal-title":"Cancer"},{"key":"BF02065528_CR12","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/hep.1840140608","volume":"14","author":"T Maeda","year":"1991","unstructured":"Maeda T, Loveland BE, Rowley MJ, Mackay IR: Autoantibody against dihydrolipoamide dehydrogenase, the E3 subunit of the 2-oxoacid dehydrogenase complexes: Significance for primary biliary cirrhosis. Hepatology 14:994\u2013999, 1991","journal-title":"Hepatology"},{"key":"BF02065528_CR13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/JCM.29.3.551-556.1991","volume":"29","author":"GJ Dawson","year":"1991","unstructured":"Dawson GJ, Lesniewski RR, Stewart JL, Boardway KM, Gutierrez RA, Pendy L, Johnson RG, Alcalde X, Rote KV, Devare SG: Detection of antibodies to hepatitis C virus in U.S. blood donors. J Clin Microbiol 29:551\u2013556, 1991","journal-title":"J Clin Microbiol"},{"key":"BF02065528_CR14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJM199010183231605","volume":"323","author":"JI Esteban","year":"1990","unstructured":"Esteban JI, Gonzalez A, Hernandez JE, Vilandomiu L, Sanchez C, Lopes-Talavera C, Lucea D, Martin-Vega C, Vidal X, Esteban R, Guardia J: Evaluation of antibody to hepatitis C virus in a study of transfusion associated hepatitis. N Engl J Med 323:1107\u20131112, 1990","journal-title":"N Engl J Med"},{"key":"BF02065528_CR15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(89)90500-X","volume":"2","author":"P Kuhnl","year":"1989","unstructured":"Kuhnl P, Seidl S, Stangel W, Beyer J, Sibrowski W, Elik J: Antibody to hepatitis C virus in German blood donors. Lancet 2:324, 1989","journal-title":"Lancet"},{"key":"BF02065528_CR16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1423-0410.1990.tb05015.x","volume":"59","author":"J Watanabe","year":"1990","unstructured":"Watanabe J, Minegishi K, Mitsumori T, Ishifuji M, Oguchi T, Ueda M, Tokunaga E, Tanaka E, Kiyosawa K, Furuta S: Prevalence of anti-HCV antibody in blood donors in the Tokyo area. Vox Sang 59:86\u201388, 1990","journal-title":"Vox Sang"},{"key":"BF02065528_CR17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00000441-198806000-00007","volume":"295","author":"A Schattner","year":"1988","unstructured":"Schattner A: Interferons and autoimmunity. Am J Med Sci 295:523\u2013544, 1988","journal-title":"Am J Med Sci"},{"key":"BF02065528_CR18","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.4049\/jimmunol.137.12.3836","volume":"127","author":"WL Farrar","year":"1986","unstructured":"Farrar WL, Birchenall-Sparks MC, Young HB: Interleukin 2 induction of interferon-gamma in RNA synthesis. J Immunol 127:3836\u20133840, 1986","journal-title":"J Immunol"},{"key":"BF02065528_CR19","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0140-6736(84)91108-5","volume":"2","author":"G Ballardini","year":"1984","unstructured":"Ballardini G, Bianchi FB, Doniach D, Mirakian R, Pisi E, Bottazzo GF: Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: Relevance to pathogenesis. Lancet 2:1009\u20131113, 1984","journal-title":"Lancet"},{"key":"BF02065528_CR20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2249.1990.tb05293.x","volume":"81","author":"A Karlsson-Parra","year":"1990","unstructured":"Karlsson-Parra A, Burman P, Hagberg H, Oberg K, Alm G, Klareskog L, Karlsson FA: Autoantibodies to epithelial cells in patients on long-term therapy with leukocyte-derived interfer-on-alpha (IFN-\u03b1). Clin Exp Immunol 81:72\u201375, 1990","journal-title":"Clin Exp Immunol"},{"key":"BF02065528_CR21","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.1840060609","volume":"6","author":"HC Mitchison","year":"1986","unstructured":"Mitchison HC, Bassendine MF, Hendrick A, Bennett MK, Bird G, Watoson AJ, James OFW: Positive antimitochondrial antibody but normal alkaline phosphatase: Is this primary biliary cirrhosis? Hepatology 6:1279\u20131284, 1986","journal-title":"Hepatology"},{"key":"BF02065528_CR22","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(68)90710-1","volume":"2","author":"JD Groote","year":"1968","unstructured":"Groote JD, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, Scheuer PJ, Schmid M, Thaler H, Uehlinger E, Wepler W: A classification of chronic hepatitis. Lancet 2:626\u2013628, 1968","journal-title":"Lancet"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02065528.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02065528\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02065528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:55:29Z","timestamp":1683176129000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02065528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1995,6]]}},"alternative-id":["BF02065528"],"URL":"https:\/\/doi.org\/10.1007\/bf02065528","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,6]]}}}